ACDM News Item

Regulatory Considerations DMEG reviews recent MHRA regulatory updates

Date: April 22, 2026

The ACDM Regulatory considerations DMEG Regulatory considerations reviewed several recent publications from the UK Medicines and Healthcare products Regulatory Agency (MHRA) including the release of new guidelines, updates to the Inspection Dossier templates and annotations to ICH E6 (R3) and ICH E8 (R1). These guidelines go into effect on April 28, 2026.

To assist data managers in complying with the new guidelines, the DMEG is releasing a summary of the highlights which impact data managers including:

o AI/ML documentation for Data Management
o Clinical trial record archiving and retention
o Data protection and subject rights

View the paper here
The Regulatory Considerations DMEG will continue to review MHRA guidance as they are published, and an upcoming review will be on the Guidance on quality and risk proportionality (published 27 March 2026). In the interim, you can access that document at the MHRA Clinical Trial Hub: https://www.gov.uk/guidance/clinical-trials-for-medicines-guidance-on-quality-and-risk-proportionality

Explore More News

Recommendation paper on decentralised elements in clinical trials

Following their meeting on 4 Oct, the EMA/HTAs and EC have published a recommendation . . .

Welcome George Clinical as a new corporate member

The ACDM: Association for Clinical Data Management is delighted to welcome George Clinical . . .

Welcome Clinion as a new corporate member

The ACDM: Association for Clinical Data Management is delighted to welcome Clinion as a . . .

Welcome ClinoSol Research as a new corporate member

The ACDM: Association for Clinical Data Management is delighted to welcome ClinoSol . . .

CTU DMEG Update

The CTU DMEG has been actively discussing common problems that data managers face in . . .

ICH E8 (R1) General Considerations for Clinical Studies Impact on Data Management

The ACDM Regulatory Considerations have reviewed the Revision 1 to the ICH E8 Guidelines . . .

ACDM Comments on “Digital Health Technologies for Remote Data Acquisition in Clinical Investigations; Draft Guidance for Industry, Investigators, and Other Stakeholders; Availability”

https://acdmglobal.org/wp-content/uploads/2022/04/ACDM_FDA_DHT.pdf

Have your say – MHRA’s public consultation on proposals for legislative changes for clinical trials

Dear Colleague, We have just launched our 8-week public consultation on proposals for . . .

Signant Health are ACDM22 Photography sponsors

The Association for Clinical Data Management are delighted to announce that Signant Health . . .

Anju Software is exhibiting at ACDM22

The Association for Clinical Data Management is delighted to announce that Anju Software . . .

SGS Health Science to sponsor ACDM Awards for the second year running

The Association for Clinical Data Management are delighted to announce that SGS Health . . .

ACDM Interactive

The ACDM would like to thank everyone involved with ACDM Interactive in Manchester. The . . .